A study on CCL1 signalling pathways has demonstrated that CCL1 derived from TAMs activates the AKT/PRAS40/mTOR signalling pathway through CCR8 in oesophageal squamous cell carcinoma (ESCC).17 This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.